Development of new immunologic approaches to cancer therapy

Steven A. Rosenberg

Research output: Contribution to journalReview articlepeer-review

Abstract

New approaches to the immunotherapy of cancer have been developed based on the adoptive transfer of activated lymphoid cells in conjunction with interleukin-2. This approach is successful in mediating the regression of established pulmonary and hepatic metastases in experimental animal models. The results of preliminary clinical trials in patients with advanced cancer have shown that this treatment approach is capable of mediating regression of cancer in humans as well.

Original languageEnglish (US)
Pages (from-to)69-76
Number of pages8
JournalBlood Purification
Volume6
Issue number2
DOIs
StatePublished - Jan 1 1988

Keywords

  • Adoptive therapy
  • Cancer
  • Immunotherapy
  • Interleukin-2

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Fingerprint

Dive into the research topics of 'Development of new immunologic approaches to cancer therapy'. Together they form a unique fingerprint.

Cite this